Institutional investors purchased a net $646.6 thousand shares of CCXI during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 51.04% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BVF PARTNERS LP Bought 257.8 Thousand shares of ChemoCentryx Inc
WASATCH ADVISORS, INC. Bought 210.0 Thousand shares of ChemoCentryx Inc
RENAISSANCE TECHNOLOGIES LLC Bought 106.6 Thousand shares of ChemoCentryx Inc